NASDAQ : OMDA
Omada Health, Inc. — Financial statements
Healthcare · Health Information Services · United States
Last price 18.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.15B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Omada Health, Inc. (OMDA) reported revenue of 309.76M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 309.76M | 260.21M | 169.80M | 122.78M | 89.19M |
| Cost of Revenue | 98.55M | 89.27M | 66.92M | 52.81M | 46.39M |
| Gross Profit | 211.21M | 170.94M | 102.88M | 69.97M | 42.79M |
| Selling, General & Admin | 162.50M | 142.23M | 110.61M | 102.23M | 88.97M |
| Research & Development | 49.17M | 40.68M | 35.92M | 33.74M | 26.17M |
| Operating Expenses | 211.68M | 182.91M | 146.53M | 135.97M | 115.14M |
| Operating Income | -464.00K | -11.97M | -43.65M | -66.00M | -72.35M |
| Interest Expense | -398.00K | -2.53M | -4.51M | -4.71M | -4.20M |
| Interest & Investment Income | 7.49M | 5.30M | 805.00K | 5.78M | 2.20M |
| Other Non Operating Income (Expenses) | -212.00K | -1.47M | 218.00K | -1.05M | 1.83M |
| EBT Excluding Unusual Items | 6.41M | -10.67M | -47.14M | -65.97M | -72.52M |
| Other Unusual Items | -2.11M | -2.11M | -1.54M | ||
| Pretax Income | 4.30M | -12.78M | -47.14M | -67.51M | -72.52M |
| Net Income | 4.30M | -12.78M | -47.14M | -67.51M | -72.52M |
| Net Income to Common | 4.30M | -12.78M | -47.14M | -67.51M | -72.52M |
| Shares Outstanding (Basic) | 58.74M | 36.64M | 7.72M | 7.09M | 6.78M |
| Shares Outstanding (Diluted) | 61.26M | 36.64M | 7.72M | 7.09M | 6.78M |
| EPS (Basic) | 0.07 | -0.35 | -6.11 | -9.52 | -10.70 |
| EPS (Diluted) | 0.07 | -0.35 | -6.11 | -9.52 | -10.70 |
| Free Cash Flow | 22.73M | 16.93M | -34.77M | -50.15M | -69.70M |
| Free Cash Flow Per Share | 0.37 | 0.46 | -4.50 | -7.07 | -10.28 |
| Gross Margin | 68.19% | 65.69% | 60.59% | 56.99% | 47.98% |
| Operating Margin | -0.15% | -4.60% | -25.71% | -53.75% | -81.12% |
| Profit Margin | 1.39% | -4.91% | -27.76% | -54.98% | -81.31% |
| Free Cash Flow Margin | 7.34% | 6.51% | -20.48% | -40.85% | -78.15% |
| EBITDA | 5.43M | -6.48M | -38.85M | -61.55M | -68.02M |
| EBITDA Margin | 1.75% | -2.49% | -22.88% | -50.13% | -76.27% |
| D&A For EBITDA | 5.89M | 5.49M | 4.80M | 4.45M | 4.33M |
| EBIT | -464.00K | -11.97M | -43.65M | -66.00M | -72.35M |
| EBIT Margin | -0.15% | -4.60% | -25.71% | -53.75% | -81.12% |
| Revenue as Reported | 309.76M | 260.21M | 169.80M | 122.78M | 89.19M |
| Advertising Expenses | 600.00K | 500.00K | 800.00K | 700.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 221.71M | 222.04M | 76.39M | 115.64M | 168.12M |
| Short-Term Investments | 284.00K | 476.00K | 30.00K | 52.00K | |
| Cash & Short-Term Investments | 221.71M | 222.32M | 76.87M | 115.67M | 168.18M |
| Receivables | 57.57M | 35.22M | 23.92M | 16.44M | 11.67M |
| Inventory | 4.12M | 4.49M | 3.30M | 3.61M | 3.54M |
| Prepaid Expenses | 7.55M | 1.54M | 797.00K | 785.00K | 608.00K |
| Other Current Assets | 3.96M | 9.37M | 8.18M | 6.37M | 4.57M |
| Total Current Assets | 294.91M | 272.93M | 113.06M | 142.88M | 188.56M |
| Property, Plant & Equipment | 9.10M | 7.94M | 6.07M | 5.60M | 6.06M |
| Goodwill | 13.24M | 13.24M | 13.24M | 13.24M | 13.24M |
| Other Intangible Assets | 1.54M | 2.41M | 4.26M | 6.27M | 8.31M |
| Long-Term Deferred Charges | 9.22M | 8.71M | 14.01M | 6.46M | 4.92M |
| Other Long-Term Assets | 215.00K | 165.00K | 244.00K | 631.00K | 710.00K |
| Total Assets | 328.22M | 305.41M | 150.89M | 175.08M | 221.80M |
| Accounts Payable | 11.80M | 10.28M | 4.17M | 3.62M | 4.11M |
| Accrued Expenses | 29.18M | 40.39M | 29.84M | 24.50M | 16.16M |
| Current Portion of Leases | 415.00K | 787.00K | 648.00K | ||
| Current Unearned Revenue | 27.70M | 25.06M | 19.53M | 14.88M | 13.44M |
| Other Current Liabilities | 6.80M | 159.00K | |||
| Total Current Liabilities | 75.48M | 75.73M | 53.95M | 43.79M | 34.51M |
| Long-Term Debt | 29.77M | 29.38M | 28.89M | ||
| Long-Term Leases | 411.00K | 1.27M | |||
| Other Long-Term Liabilities | 2.54M | 2.58M | 1.52M | ||
| Total Liabilities | 75.48M | 75.73M | 86.26M | 76.16M | 66.19M |
| Common Stock | 61.00K | 58.00K | 8.00K | 22.00K | 21.00K |
| Additional Paid-In Capital | 707.10M | 686.37M | 59.55M | 46.70M | 36.12M |
| Retained Earnings | -454.42M | -456.74M | -443.97M | -396.83M | -329.32M |
| Total Common Equity | 252.74M | 229.68M | -384.40M | -350.11M | -293.17M |
| Shareholders' Equity | 252.74M | 229.68M | 64.63M | 98.92M | 155.60M |
| Total Liabilities & Equity | 328.22M | 305.41M | 150.89M | 175.08M | 221.80M |
| Total Debt | 30.19M | 30.58M | 30.81M | ||
| Net Cash (Debt) | 221.71M | 222.32M | 46.68M | 85.09M | 137.37M |
| Net Cash Per Share | 3.62 | 6.07 | 6.05 | 12.00 | 20.26 |
| Filing Date Shares Outstanding | 61.22M | 58.93M | 8.16M | 7.39M | 6.78M |
| Total Common Shares Outstanding | 60.61M | 58.43M | 8.16M | 7.39M | 6.78M |
| Working Capital | 219.43M | 197.21M | 59.11M | 99.09M | 154.04M |
| Book Value Per Share | 4.17 | 3.93 | -47.12 | -47.39 | -43.24 |
| Tangible Book Value | 237.96M | 214.03M | -401.91M | -369.62M | -314.73M |
| Tangible Book Value Per Share | 3.93 | 3.66 | -49.27 | -50.03 | -46.42 |
| Machinery | 2.88M | 2.97M | 2.74M | 3.64M | |
| Leasehold Improvements | 829.00K | 829.00K | 829.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | 4.30M | -12.78M | -47.14M | -67.51M | -72.52M |
| Depreciation & Amortization | 5.89M | 5.89M | 5.50M | 4.45M | 4.33M |
| Other Amortization | 3.74M | 3.62M | 3.03M | 2.21M | 1.85M |
| Loss (Gain) From Sale of Assets | 33.00K | 8.00K | 2.00K | 151.00K | 6.00K |
| Stock-Based Compensation | 17.12M | 12.96M | 9.42M | 8.74M | 6.65M |
| Provision & Write-off of Bad Debts | 1.89M | 1.19M | 1.76M | 452.00K | 239.00K |
| Other Operating Activities | 2.39M | 3.62M | -190.00K | 3.27M | -395.00K |
| Change in Accounts Receivable | -25.17M | -12.36M | -8.80M | -5.34M | -3.93M |
| Change in Inventory | -650.00K | -1.19M | 318.00K | -74.00K | -1.95M |
| Change in Accounts Payable | 6.80M | 6.29M | 399.00K | -286.00K | -4.99M |
| Change in Unearned Revenue | 2.18M | 5.53M | 4.64M | 1.44M | 1.78M |
| Change in Other Net Operating Assets | 5.17M | 5.47M | -3.13M | 2.75M | -60.00K |
| Operating Cash Flow | 23.68M | 18.25M | -34.18M | -49.74M | -68.98M |
| Capital Expenditures | -960.00K | -1.32M | -596.00K | -416.00K | -720.00K |
| Sale (Purchase) of Intangibles | -5.59M | -4.51M | -3.27M | -2.50M | -2.00M |
| Investing Cash Flow | -6.55M | -5.83M | -3.86M | -2.92M | -2.72M |
| Long-Term Debt Issued | 30.96M | ||||
| Long-Term Debt Repaid | -30.96M | -30.00M | |||
| Net Debt Issued (Repaid) | -30.96M | -30.96M | 963.00K | ||
| Issuance of Common Stock | 16.84M | 169.90M | 3.33M | 1.75M | 1.74M |
| Other Financing Activities | -3.79M | -5.71M | -4.54M | -2.54M | |
| Financing Cash Flow | -18.57M | 133.22M | -1.21M | 179.00K | 16.32M |
| Net Cash Flow | -1.43M | 145.64M | -39.25M | -52.48M | -55.38M |
| Free Cash Flow | 22.73M | 16.93M | -34.77M | -50.15M | -69.70M |
| Free Cash Flow Margin | 7.34% | 6.51% | -20.48% | -40.85% | -78.15% |
| Free Cash Flow Per Share | 0.37 | 0.46 | -4.50 | -7.07 | -10.28 |
| Levered Free Cash Flow | 11.92M | 15.34M | -14.46M | -29.39M | |
| Unlevered Free Cash Flow | 12.13M | 16.64M | -12.03M | -26.87M | |
| Cash Interest Paid | 626.00K | 2.42M | 3.85M | 4.09M | 3.61M |
| Change in Working Capital | -11.68M | 3.74M | -6.57M | -1.50M | -9.14M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 1.09B | 913.46M | |||
| Enterprise Value | 871.01M | 714.83M | |||
| Last Close Price | 18.73 | 15.78 | |||
| PS Ratio | 3.54 | 3.51 | |||
| PB Ratio | 4.49 | 3.98 | |||
| P/TBV Ratio | 4.61 | 4.27 | |||
| P/FCF Ratio | 48.25 | 53.95 | |||
| P/OCF Ratio | 46.29 | 50.05 | |||
| EV/Sales Ratio | 2.82 | 2.75 | |||
| EV/FCF Ratio | 38.49 | 42.22 | |||
| Debt / Equity Ratio | 0.47 | 0.31 | 0.20 | ||
| Net Debt / Equity Ratio | -0.88 | -0.97 | -0.72 | -0.86 | -0.88 |
| Net Debt / EBITDA Ratio | -40.82 | 34.30 | 1.20 | 1.38 | 2.02 |
| Net Debt / FCF Ratio | -9.76 | -13.13 | 1.34 | 1.70 | 1.97 |
| Asset Turnover | 0.98 | 1.14 | 1.04 | 0.62 | |
| Inventory Turnover | 25.97 | 22.94 | 19.37 | 14.77 | |
| Quick Ratio | 3.70 | 3.40 | 1.87 | 3.02 | 5.21 |
| Current Ratio | 3.91 | 3.60 | 2.10 | 3.26 | 5.46 |
| Return on Equity (ROE) | 1.84% | -8.68% | -57.64% | -53.05% | |
| Return on Assets (ROA) | -0.09% | -3.28% | -16.74% | -20.79% | |
| Return on Capital Employed (ROCE) | -0.20% | -5.20% | -45.00% | -50.30% | -38.60% |
| Earnings Yield | 0.41% | -1.40% | |||
| FCF Yield | 2.07% | 1.85% | |||
| Buyback Yield / Dilution | -433.19% | -374.54% | -8.88% | -4.59% |